A Population-Based Study of Simvastatin Drug-Drug Interactions in Cardiovascular Disease Patients.


Journal

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science
ISSN: 2153-4063
Titre abrégé: AMIA Jt Summits Transl Sci Proc
Pays: United States
ID NLM: 101539486

Informations de publication

Date de publication:
2020
Historique:
entrez: 2 6 2020
pubmed: 2 6 2020
medline: 2 6 2020
Statut: epublish

Résumé

Simvastatin is a commonly used medication for lipid management and cardiovascular disease, however, the risk of adverse events (AEs) with its use increases via drug-drug interaction (DDI) exposures. Patients were extracted if initially diagnosed with cardiovascular disease and newly initiated simvastatin therapy. The cohort was divided into a DDI-exposed group and a non-DDI exposed group. The DDI-exposed group was further divided into gemfibrozil, clarithromycin, and erythromycin exposure groups. The outcome was defined as a composite of predefined AEs. Our results show that the simvastatin-DDI group had a higher illness burden with longer simvastatin exposure time and more medical care follow-up compared with the simvastatin-non-DDI exposed group. AEs occurred more frequently in subjects exposed to interacting drugs with a higher risk for clarithromycin and erythromycin exposed subjects than for gemfibrozil subjects.

Identifiants

pubmed: 32477689
pmc: PMC7233072

Types de publication

Journal Article

Langues

eng

Pagination

664-673

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL143390
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Informations de copyright

©2020 AMIA - All rights reserved.

Références

Lipids Health Dis. 2015 Oct 24;14:131
pubmed: 26497728
Am J Cardiol. 2006 Apr 17;97(8A):27C-31C
pubmed: 16581325
Eur J Clin Pharmacol. 2001 Aug;57(5):357-64
pubmed: 11599653
Br J Clin Pharmacol. 2004 Jul;58(1):56-60
pubmed: 15206993
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
J Clin Lipidol. 2008 Dec;2(6):453-63
pubmed: 21291779
Expert Opin Drug Saf. 2012 Nov;11(6):933-46
pubmed: 22866966
Pharmacogenet Genomics. 2015 Dec;25(12):595-608
pubmed: 26367500
Drug Metab Dispos. 2007 May;35(5):779-86
pubmed: 17296622
Drug Metab Dispos. 1997 May;25(5):623-30
pubmed: 9152603
South Med J. 1997 May;90(5):546-7
pubmed: 9160078
Br J Clin Pharmacol. 2003 Jul;56(1):120-4
pubmed: 12848784
Ann Intern Med. 2013 Jun 18;158(12):869-76
pubmed: 23778904
Methods Mol Biol. 2019;1939:255-272
pubmed: 30848466
Am Fam Physician. 2007 Aug 1;76(3):391-6
pubmed: 17708140
Lancet. 2015 Jun 6;385(9984):2264-2271
pubmed: 25748612
Future Cardiol. 2016 May;12(3):289-315
pubmed: 27079178
Clin Nucl Med. 2004 Dec;29(12):803-4
pubmed: 15545884
Clin Pharmacol Ther. 1998 Nov;64(5):477-83
pubmed: 9834039
Pharmacogenet Genomics. 2008 May;18(5):424-33
pubmed: 18408565
Eur J Clin Pharmacol. 2018 Apr;74(4):525-534
pubmed: 29255993
Gastroenterology. 2006 May;130(6):1793-806
pubmed: 16697742
J Gen Intern Med. 2004 Jun;19(6):638-45
pubmed: 15209602
Br J Pharmacol. 2009 Oct;158(3):693-705
pubmed: 19785645
Mol Pharmacol. 2005 Oct;68(4):1031-8
pubmed: 16046661
Medicine (Baltimore). 2016 Jan;95(2):e2487
pubmed: 26765458
Heart. 2008 Oct;94(10):1331-2
pubmed: 18701534
Clin Pharmacol Ther. 2010 Jan;87(1):130-3
pubmed: 19890253
Clin Ther. 2006 Jan;28(1):26-35
pubmed: 16490577
Drugs. 2010 Jul 30;70(11):1363-79
pubmed: 20614945
Am J Med. 2001 Oct 1;111(5):390-400
pubmed: 11583643
JAMA. 2004 Dec 1;292(21):2585-90
pubmed: 15572716
Clin Pharmacol Ther. 2006 Dec;80(6):565-81
pubmed: 17178259
NCHS Data Brief. 2014 Dec;(177):1-8
pubmed: 25536410
Ann Pharmacother. 2001 Jan;35(1):26-31
pubmed: 11197581
Drug Metab Dispos. 1997 Nov;25(11):1228-33
pubmed: 9351897
Pharmacotherapy. 2007 Apr;27(4):603-7
pubmed: 17381388
Ann Intern Med. 2009 Jun 16;150(12):858-68
pubmed: 19528564
Drug Saf. 1993 Jul;9(1):51-9
pubmed: 8347291
AMIA Annu Symp Proc. 2015 Nov 05;2015:287-96
pubmed: 26958159
J Cell Mol Med. 2001 Oct-Dec;5(4):378-87
pubmed: 12067471
West J Nurs Res. 2017 Jan;39(1):42-62
pubmed: 30208771
J Pharm Pharmacol. 2005 Oct;57(10):1305-11
pubmed: 16259759
J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S30-46
pubmed: 24793440

Auteurs

Jin Wang (J)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Chih-Lin Chi (CL)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
School of Nursing, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Wendy L St Peter (WL)

College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

Angie Carlson (A)

College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

Matt Loth (M)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
School of Nursing, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Prajwal Mani Pradhan (PM)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Yue Liang (Y)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Wei-Yu Chen (WY)

Department of Computer Science & Engineering, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Tatiana Lenskaia (T)

Bioinformatics and Computational Biology program, University of Minnesota, Minneapolis, MN, USA.
OptumLabs Visiting Fellow, Cambridge, MA, USA.

Jennifer G Robinson (JG)

Departments of Epidemiology & Medicine, University of Iowa, IA, USA.

Terrence J Adam (TJ)

Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.
College of Pharmacy, University of Minnesota, Minneapolis, MN, USA.

Classifications MeSH